Cargando…

Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability and Provides Effective Immune Protection against Lethal H7N9 Virus Challenge in Chickens

H7N9 avian influenza virus (AIV) has caused huge losses in the poultry industry and impacted human public health security, and still poses a potential threat. Currently, immune prevention and control of avian influenza relies on traditional inactivated vaccines; however, they have some limitations a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Taoran, Kong, Dexin, Hu, Xiaolong, Gao, Yinze, Lin, Shaorong, Liao, Ming, Fan, Huiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460070/ https://www.ncbi.nlm.nih.gov/pubmed/37631886 http://dx.doi.org/10.3390/vaccines11081318

Ejemplares similares

Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens
por: Kong, Dexin, et al.
Publicado: (2022)

Global Prevalence and Hemagglutinin Evolution of H7N9 Avian Influenza Viruses from 2013 to 2022
por: Liu, Qianshuo, et al.
Publicado: (2023)

Antigenic structure of the hemagglutinin of H9N2 influenza viruses
por: Okamatsu, Masatoshi, et al.
Publicado: (2008)

Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs
por: Ridenour, Callie, et al.
Publicado: (2015)

Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
por: Jang, Hyesun, et al.
Publicado: (2020)

Identifying novel amino acid substitutions of hemagglutinin involved in virulence enhancement in H7N9 virus strains
por: Zhang, Ting, et al.
Publicado: (2021)

A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
por: Li, Jingxin, et al.
Publicado: (2022)

Development of mouse monoclonal antibody for detecting hemagglutinin of avian influenza A(H7N9) virus and preventing virus infection
por: Chiang, Yi-Wei, et al.
Publicado: (2021)

Development of Rapid Immunochromatographic Test for Hemagglutinin Antigen of H7 Subtype in Patients Infected with Novel Avian Influenza A (H7N9) Virus
por: Kang, Keren, et al.
Publicado: (2014)

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
por: Schmeisser, Falko, et al.
Publicado: (2015)

N (2)-(7-Bromo-9-butyl-9H-carbazol-2-yl)-9,9-diethyl-N (2),N (7),N (7)-triphenyl-9H-fluorene-2,7-diamine
por: Baheti, Abhishek, et al.
Publicado: (2012)

Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus
por: Xu, Qi, et al.
Publicado: (2013)

Coinfection of Chickens with H9N2 and H7N9 Avian Influenza Viruses Leads to Emergence of Reassortant H9N9 Virus with Increased Fitness for Poultry and a Zoonotic Potential
por: Bhat, Sushant, et al.
Publicado: (2022)

Comparative Pathogenicity and Transmissibility of the H7N9 Highly Pathogenic Avian Influenza Virus and the H7N9 Low Pathogenic Avian Influenza Virus in Chickens
por: Yu, Hao, et al.
Publicado: (2019)

Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution
por: Kok, Adinda, et al.
Publicado: (2023)

H7N9 flu
por: Lina, Bruno
Publicado: (2014)

A replication-deficient H9N2 influenza virus carrying H5 hemagglutinin conferred protection against H9N2 and H5N1 influenza viruses in mice
por: Ren, Weigang, et al.
Publicado: (2022)

The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice
por: Zheng, Jian, et al.
Publicado: (2015)

Genetic Characterization and Pathogenicity of H7N7 and H7N9 Avian Influenza Viruses Isolated from South Korea
por: Na, Eun-Jee, et al.
Publicado: (2021)

220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development
por: Liu, Liqi, et al.
Publicado: (2018)

Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity
por: Chang, Pengxiang, et al.
Publicado: (2018)

The S128N mutation combined with an additional potential N-linked glycosylation site at residue 133 in hemagglutinin affects the antigenicity of the human H7N9 virus
por: Liu, Wanli, et al.
Publicado: (2016)

Genetic and biological properties of H7N9 avian influenza viruses detected after application of the H7N9 poultry vaccine in China
por: Yin, Xin, et al.
Publicado: (2021)

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
por: Hessel, Annett, et al.
Publicado: (2014)

Impact of the variations in potential glycosylation sites of the hemagglutinin of H9N2 influenza virus
por: Peng, Qianqian, et al.
Publicado: (2018)

H7N9 avian influenza virus - search and re-search
por: Wen, Yu-Mei, et al.
Publicado: (2013)

HUMAN INFECTION WITH AVIAN INFLUENZA A (H7N9) VIRUS
por: Zhang, Yi, et al.
Publicado: (2014)

Genomic Signatures for Avian H7N9 Viruses Adapting to Humans
por: Chen, Guang-Wu, et al.
Publicado: (2016)

Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice
por: Mok, Chris Ka Pun, et al.
Publicado: (2013)

H7N9 avian influenza virus - search and re-search
por: Wen, Yu-Mei, et al.
Publicado: (2013)

Evolution and Adaptation of the Avian H7N9 Virus into the Human Host
por: Bisset, Andrew T., et al.
Publicado: (2020)

Avian Influenza H7N9 Virus Adaptation to Human Hosts
por: Tan, Swan, et al.
Publicado: (2021)

Immune Enhancement by the Tetra-Peptide Hydrogel as a Promising Adjuvant for an H7N9 Vaccine against Highly Pathogenic H7N9 Virus
por: Wu, Xiaoxin, et al.
Publicado: (2022)

Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
por: Lin, Yong Ping, et al.
Publicado: (2016)

Yeast display platform technology to prepare oral vaccine against lethal H7N9 virus challenge in mice
por: Lei, Han, et al.
Publicado: (2020)

PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses
por: Xiao, Chencheng, et al.
Publicado: (2016)

Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
por: Hatta, Masato, et al.
Publicado: (2018)

Complete Genome Sequence of an H9N2 Influenza Virus Lethal to Chickens
por: Zhang, Yi, et al.
Publicado: (2014)

Quantitative Characterization of Glycan-Receptor Binding of H9N2 Influenza A Virus Hemagglutinin
por: Srinivasan, Karunya, et al.
Publicado: (2013)

Characterization of the Sialic Acid Binding Activity of Influenza A Viruses Using Soluble Variants of the H7 and H9 Hemagglutinins
por: Sauer, Anne-Kathrin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2j6m8lup3226furbm2chkap4d1